NCT01404832View on ClinicalTrials.gov

The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump Inhibitors

PHASE4TerminatedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Gastroesophageal Reflux DiseaseEosinophilic Esophagitis
Interventions
DRUG

Treat with lansoprazole 30 mg BID for 2 weeks, endoscopic examination with esophageal biopsy for patients with persistent symptoms

Treat with lansoprazole 30 mg BID for 2 weeks, perform endoscopic examination with esophageal biopsy

Trial Locations (1)

75216

Dallas VA Medical Center, Dallas

Sponsors
All Listed Sponsors
collaborator

TAP Pharmaceutical Products Inc.

INDUSTRY

lead

Dallas VA Medical Center

FED